Lam Research Corporation $LRCX Holdings Lessened by Wealth Architects LLC

Key Points

• Wealth Architects LLC cut its Lam Research stake by 32.3% in the second quarter, selling 85,020 shares and retaining 178,222 shares valued at approximately $77.2 million. Lam remains the firm’s second-largest holding and represents 6.1% of its portfolio.
• Lam Research reported strong quarterly results, with EPS of $1.82 exceeding the $1.69 estimate and revenue rising 30% year over year to $6.72 billion. The company issued Q1 2027 EPS guidance of $2.00–$2.30.
• Analyst sentiment remains favorable, with a consensus “Moderate Buy” rating and average price target of $358.47, although some firms recently lowered targets. Institutional investors own 84.61% of the stock, while insiders sold more than $27.6 million in shares over the past three months.

Wealth Architects LLC trimmed its holdings in shares of Lam Research Corporation (NASDAQ:LRCX - Free Report) by 32.3% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 178,222 shares of the semiconductor company's stock after selling 85,020 shares during the quarter. Lam Research makes up about 6.1% of Wealth Architects LLC's investment portfolio, making the stock its 2nd largest holding. Wealth Architects LLC's holdings in Lam Research were worth $77,229,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Norges Bank bought a new stake in shares of Lam Research during the 4th quarter valued at $3,645,427,000. Price T Rowe Associates Inc. MD raised its holdings in Lam Research by 352.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 13,695,210 shares of the semiconductor company's stock worth $2,344,347,000 after purchasing an additional 10,666,540 shares during the period. Franklin Resources Inc. raised its holdings in Lam Research by 57.0% in the 4th quarter. Franklin Resources Inc. now owns 10,110,560 shares of the semiconductor company's stock worth $1,730,724,000 after purchasing an additional 3,671,073 shares during the period. Corient Private Wealth LLC lifted its position in Lam Research by 235.5% during the fourth quarter. Corient Private Wealth LLC now owns 5,199,441 shares of the semiconductor company's stock valued at $890,040,000 after purchasing an additional 3,649,553 shares in the last quarter. Finally, J. Stern & Co. LLP lifted its position in Lam Research by 3,826.9% during the fourth quarter. J. Stern & Co. LLP now owns 3,459,377 shares of the semiconductor company's stock valued at $592,176,000 after purchasing an additional 3,371,283 shares in the last quarter. 84.61% of the stock is owned by hedge funds and other institutional investors.

Lam Research Price Performance

Shares of Lam Research stock opened at $314.00 on Friday. The company has a market capitalization of $392.91 billion, a price-to-earnings ratio of 54.51, a PEG ratio of 1.25 and a beta of 1.84. The company has a quick ratio of 1.91, a current ratio of 2.63 and a debt-to-equity ratio of 0.30. The stock's 50-day simple moving average is $337.47 and its 200-day simple moving average is $286.09. Lam Research Corporation has a 52 week low of $94.11 and a 52 week high of $438.50.

Lam Research (NASDAQ:LRCX - Get Free Report) last released its earnings results on Wednesday, July 29th. The semiconductor company reported $1.82 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.69 by $0.13. The firm had revenue of $6.72 billion during the quarter, compared to analysts' expectations of $6.66 billion. Lam Research had a return on equity of 67.60% and a net margin of 31.27%.The firm's revenue was up 30.0% on a year-over-year basis. During the same quarter last year, the business posted $1.33 earnings per share. Lam Research has set its Q1 2027 guidance at 2.000-2.300 EPS. As a group, analysts expect that Lam Research Corporation will post 9.32 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. B. Riley Financial cut their price target on Lam Research from $385.00 to $350.00 and set a "buy" rating for the company in a report on Thursday, July 30th. Wall Street Zen cut Lam Research from a "buy" rating to a "hold" rating in a research report on Sunday, May 10th. Susquehanna reaffirmed a "positive" rating and set a $475.00 price objective (up from $385.00) on shares of Lam Research in a research report on Tuesday, June 30th. Zacks Research upgraded Lam Research from a "hold" rating to a "strong-buy" rating in a research note on Friday, July 17th. Finally, Deutsche Bank Aktiengesellschaft restated a "buy" rating and set a $320.00 target price on shares of Lam Research in a research note on Thursday, July 30th. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, Lam Research presently has a consensus rating of "Moderate Buy" and an average price target of $358.47.

Insiders Place Their Bets

In other Lam Research news, Director Eric Brandt sold 54,500 shares of the stock in a transaction that occurred on Thursday, June 11th. The shares were sold at an average price of $350.80, for a total transaction of $19,118,600.00. Following the completion of the sale, the director directly owned 199,205 shares of the company's stock, valued at $69,881,114. This trade represents a 21.48% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Abhijit Y. Talwalkar sold 18,282 shares of the stock in a transaction that occurred on Monday, July 13th. The shares were sold at an average price of $335.00, for a total transaction of $6,124,470.00. Following the sale, the director directly owned 87,142 shares of the company's stock, valued at approximately $29,192,570. This trade represents a 17.34% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 80,441 shares of company stock worth $27,614,296 in the last three months. 0.31% of the stock is owned by company insiders.

Lam Research Profile

Lam Research Corporation NASDAQ: LRCX is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam's product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source